Delivery Order SPE2DR25D7059-SPE2DR26F7NBA
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $11,897.40. This firm fixed-price delivery order represents a non-competitive, non-set-aside procurement with an ultimate completion date of November 14, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,273.92 to AmerisourceBergen Drug Corp for Rifampin 150 mg capsules (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Rifampin 300 mg capsules (30-count units) with a ceiling value of $1,789.57. This firm fixed-price delivery order represents a non-set-aside competitive award and is scheduled for completion by July 15, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,707.48 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules in unit dose packaging (100 count). The contract was competitively awarded without set-aside provisions under a firm fixed price arrangement, with an ultimate completion date of August 14, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,053.30 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) under a firm fixed-price contract. The award, issued on September 26, 2025, with an ultimate completion date of September 29, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. Rifampin...
- The Defense Logistics Agency awarded a Delivery Order to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) under a firm fixed-price contract valued at $4,367.12, with an ultimate completion date of December 11, 2025. This non-set-aside award represents a single delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) valued at $2,401.32, with an ultimate completion date of August 27, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a Delivery Order (4570100654) to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count) with a ceiling value of $3,489.33. This is a firm fixed-price delivery order awarded on November 25, 2025, with an ultimate completion date of November 26, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used for this competitive award. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $5,984.18 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Rifampin 300 mg capsules in quantities of 60 units. The contract is a firm fixed price delivery order with an ultimate completion date of July 31, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,232.41 to AmerisourceBergen Drug Corp for Rifampin 300 mg capsules (60-count units) on December 2, 2025, with completion scheduled for December 3, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in...
- SPE2DR25D7059Indefinite Delivery Contract
- SPE2DR25D7059-SPE2DR26F7NBADelivery Order
This delivery order, valued at $1,061.60, awards Amerisourcebergen Drug Corp the supply of Rifampin 150 mg capsules (30-count units) for the Defense Logistics Agency (DLA). The contract is non-set-aside and employs firm fixed price terms, with an ultimate completion date of December 18, 2025. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This award is issued as a child delivery order under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal military and veteran healthcare procurement through the DLA Medical Supply Chain. Rifampin is an antibiotic commonly used in treating tuberculosis and other mycobacterial infections, representing the type of essential pharmaceutical commodity that supports military readiness and healthcare operations. The company's substantial prime IDC vehicle enables flexible fulfillment of pharmaceutical needs across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/16/25 |